logo-loader
AIM:APH FRA:DVL

Alliance Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£354.01 m
Price
66.80 GBX
Change
4.87%
52 weeks high
88.90
52 weeks low
55.25

In brief

Alliance Pharma plc (AIM:APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.

We currently own or license the rights to more than 90 consumer healthcare products and pharmaceuticals, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused on a small number of brands with significant international or multi-territory reach. The remainder of the portfolio comprises products which are sold in a limited number of local markets and require little or no promotional investment.

Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.

For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com 

Deep dive We explore the investor case for growth companies

Snapshot

  • Turnover up 16% in 2019
  • Integrating Nizoral acquisition from Johnson & Johnson 
  • Organic growth in star brands up
  • Further acquisitions eyed 

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Alliance Pharma: Star brands and Asia underpin drugs group's financial performance

The company said it was on track to hit full-year expectations as it delivered a solid first-half performance

on 09/24/2019